The effect of weight, body mass index, age, sex , and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis
Clinical Pharmacology: Advances and Applications · 2016
DOI: 10.2147/cpaa.s108966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2016. Verfasst von Sagar Munjal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Clinical Development and Medical Affairs, Dr. Reddy's Laboratories Ltd, Princeton, NJ, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology Clinical Development and Medical Affairs, Dr. Reddy's Laboratories Ltd, Princeton, NJ, USA.
- Pharmacokinetics, Modeling and Simulation & Bioanalysis, Dr. Reddy's Laboratories Ltd, Hyderabad, India.
- Department of Neurology, The David Geffen School of Medicine, University of California, Los Angeles, Los Angeles.
- P Less Than, San Francisco, CA, USA.
Zitieren
APA
Munjal, S., Gautam, A., Rapoport, A. M., & Fisher, D. M. (2016). The effect of weight, body mass index, age, sex , and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis. Clinical Pharmacology: Advances and Applications. https://doi.org/10.2147/cpaa.s108966
Vancouver
Munjal S, Gautam A, Rapoport AM, Fisher DM. The effect of weight, body mass index, age, sex , and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis. Clinical Pharmacology: Advances and Applications. 2016. doi:10.2147/cpaa.s108966
BibTeX
@article{Munjal2016,
author = {Munjal, Sagar and Gautam, Anirudh and Rapoport, Alan M and Fisher, Dennis M},
title = {The effect of weight, body mass index, age, sex , and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis},
journal = {Clinical Pharmacology: Advances and Applications},
year = {2016},
doi = {10.2147/cpaa.s108966}
}
EUVIMED